Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

INTERIM MANAGEMENT STATEMENT

23 May 2024 10:44

RNS Number : 6667P
Mandarin Oriental International Ltd
23 May 2024
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

23rd May 2024 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2024.

 

In March 2024, the Group completed a comprehensive review and refresh of its strategy to deliver its objective of being a brand-led, guest-centric, global luxury hospitality business which generates strong returns for hotel owners and partners and creates value for shareholders. The main pillars of the strategy are to:

 

· continue to elevate Mandarin Oriental to a distinct high-end luxury brand;

· accelerate the expansion of the Management Business globally; and

· consistently innovate to deliver brand-defining experiences to customers.

 

We are now moving forward to execute against those pillars and objectives.

 

On the development front, earlier this year, the Group completed the rebranding of Mandarin Oriental Al Faisaliah, Riyadh, our debut hotel in Saudi Arabia, and opened Mandarin Oriental Residences, Fifth Avenue in New York. The Group expects to open three more new hotels during 2024: Mandarin Oriental, Muscat, Mandarin Oriental Mayfair, London, and Mandarin Oriental Qianmen, Beijing. In May, the Group announced a new management contract for a luxury hotel in Rome, scheduled to open in 2026. In April, the Group completed the sale of the hotel property of Mandarin Oriental, Paris, while retaining a long-term management contract.

 

Revenue per Available Room ('RevPAR') improved further as a result of strong performance across all regions in the first quarter of 2024. Hotels in Asia delivered notable growth compared to the same period last year, driven by the recovery of Chinese mainland outbound tourism and the return of international travellers to China. In Europe, the Middle East and Africa, hotels maintained high levels of average rates, bolstered by sustained leisure demand in the region and the Group's attractive portfolio of hotels in appealing destinations. In America, RevPAR increased over the same quarter last year, primarily due to an increase in occupancy from corporate business.

 

The Group recorded a small underlying profit in the first quarter, in line with expectations. The Management Business generated solid fee income from hotels and the sale of branded residences. Owned Hotels in Asia, particularly Singapore and Tokyo, recorded commendable improvements in earnings compared to the first quarter of last year, partially offset by lower contributions from Europe and America.

 

Consolidated net debt slightly increased from US$225 million at 31st December 2023 to US$254 million at 31st March 2024, mainly due to investment in One Causeway Bay, the Group's mixed-use commercial redevelopment in Hong Kong - and ahead of funds received in April from the hotel property sale in Paris. The Group's liquidity position remains robust, with US$320 million in available committed debt facilities and US$154 million in cash reserves. Gearing was 6% of adjusted shareholders' funds at 31st March 2024.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Max Fleming

Director of Corporate Finance (852) 2895 9171

 

Chris Orlikowski

Director of Global Communications (44) 791 7280 210

Brunswick Group Limited

William Brocklehurst (852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKXLBLZELZBBL
Date   Source Headline
29th May 202610:53 amRNSTotal Voting Rights
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 202611:31 amRNSTransaction in Own Shares
27th May 202610:27 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSAcquisition of I-MED Radiology Network
22nd May 202610:23 amRNSInterim Management Statement
19th May 202612:22 pmRNSINTERIM MANAGEMENT STATEMENT
18th May 202612:57 pmRNSNotification of Issuance of Equity Securities
18th May 202612:30 pmRNSDirector/PDMR Shareholding
7th May 20261:01 pmRNSAdditional Listing
7th May 202612:49 pmRNSDirector/PDMR Shareholding
7th May 202612:44 pmRNSResult of AGM
5th May 202610:54 amRNSTransaction in Own Shares
5th May 202610:19 amRNSTransaction in Own Shares
30th Apr 202611:51 amRNSTotal Voting Rights
30th Apr 202611:50 amRNSTransaction in Own Shares
30th Apr 202610:47 amRNSJC&C Interim Management Statement
29th Apr 202612:28 pmRNSPT Astra 2026 First Quarter Financial Statements
29th Apr 202611:59 amRNSTransaction in Own Shares
29th Apr 202610:48 amRNSDividend
28th Apr 202611:35 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202611:26 amRNSDividend
22nd Apr 202611:12 amRNSTransaction in Own Shares
21st Apr 202610:57 amRNSTransaction in Own Shares
20th Apr 202611:01 amRNSTransaction in Own Shares
14th Apr 202611:31 amRNSTransaction in Own Shares
13th Apr 202611:27 amRNSTransaction in Own Shares
10th Apr 202611:23 amRNSTransaction in Own Shares
8th Apr 202611:53 amRNSTransaction in Own Shares
8th Apr 202610:25 amRNSAnnual Financial Report
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20268:02 amRNSTransaction in Own Shares
1st Apr 202611:17 amRNSTransaction in Own Shares
1st Apr 202610:34 amRNSCirc re. Scrip Dividend Scheme
1st Apr 202610:21 amRNSDirector/PDMR Shareholding
31st Mar 202611:59 amRNSDirector/PDMR Shareholding
31st Mar 202611:53 amRNSTotal Voting Rights
31st Mar 202611:46 amRNSTransaction in Own Shares
30th Mar 202611:08 amRNSTransaction in Own Shares
27th Mar 20269:43 amRNSDirector/PDMR Shareholding
25th Mar 202611:05 amRNSDirector/PDMR Shareholding
25th Mar 202610:31 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:07 amRNSTransaction in Own Shares
20th Mar 20269:26 amRNSDirector/PDMR Shareholding
17th Mar 20269:55 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
13th Mar 20269:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.